Testing effectiveness (Phase 2)Study completedNCT01356862
What this trial is testing
Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer
Who this might be right for
Breast Cancer
Alliance Pour La Recherche en Cancerologie 91